Evidence map›Paper›PMID 29715296›Full record

Trial reportPloS one2018

Effects of isomaltodextrin in postprandial lipid kinetics: Rat study and human randomized crossover study.

Ryodai Takagaki, Yuki Ishida, Tsuyoshi Sadakiyo, Yoshifumi Taniguchi, Takeo Sakurai, Hitoshi Mitsuzumi, Hikaru Watanabe, Shigeharu Fukuda, Shimpei Ushio

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ryodai TakagakiR&D Center, Hayashibara Co., Ltd., Okayama, Japan.ORCID 0000-0001-5732-5744
Yuki IshidaR&D Center, Hayashibara Co., Ltd., Okayama, Japan.
Tsuyoshi SadakiyoR&D Center, Hayashibara Co., Ltd., Okayama, Japan.
Yoshifumi TaniguchiR&D Center, Hayashibara Co., Ltd., Okayama, Japan.
Takeo SakuraiR&D Center, Hayashibara Co., Ltd., Okayama, Japan.
Hitoshi MitsuzumiR&D Center, Hayashibara Co., Ltd., Okayama, Japan.
Hikaru WatanabeR&D Center, Hayashibara Co., Ltd., Okayama, Japan.
Shigeharu FukudaR&D Center, Hayashibara Co., Ltd., Okayama, Japan.
Shimpei UshioR&D Center, Hayashibara Co., Ltd., Okayama, Japan.
Hayashibara (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Isomaltodextrin (IMD) is a novel dietary fiber-like polysaccharide: a type of α-glucan produced from starch using enzymes derived from microorganisms. The results of cohort studies show that dietary fiber can prevent cardiovascular disorders caused by lifestyle-related diseases such as metabolic syndrome. Inhibition of excess fat absorption by dietary fiber is known to be one of the mechanisms, and it is also known that the actions of dietary fiber vary depending on factors such as its structure or origin. Thus, we investigated the inhibitory actions of IMD on fat absorption, and analyzed its mechanism of action. In rats, the absorption of fat given by gavage was significantly lower at 1, 2, and 6 hours after IMD administration than after vehicle administration. In humans, IMD was associated with a lesser increase in blood triglycerides in subjects whose blood triglycerides were otherwise apt to rise. We also found by in vitro emulsion studies that IMD, which had no effect on digestive enzyme activity or emulsion formation, stabilized the micro size micelle by inducing enlarged micelle particle size and increased zeta potential. In conclusion, the mechanism of inhibition of fat absorption by IMD may be a delay in micelle particles accessing the intestinal epithelium through changes in the surface structure and the physical properties of the micelle particles.

Indexed as

AdultAgedAnimalsCross-Over StudiesDietary FatsDietary FiberEmulsionsFemaleHumansIntestinal MucosaKineticsLipidsMaleMicellesMiddle AgedParticle SizeDietary FatsDietary FiberEmulsionsLipidsMicellesPolysaccharidesTriglycerides

Identifiers

PMID29715296
PMCPMC5929559
OpenAlexW2802203073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.